The coupling of PD (Programmed cell Death protein)-1 on lymphocytes and its ligand PD-L1, which can be expressed on tumor cells and tumor-infiltrating antigen-presenting cells, limits the activity of effector T cells against tumors [3,4,5]. Here, PDCD1 is linked to neoplasm.